Menu
GeneBe

rs34967349

Variant summary

Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_002292.4(LAMB2):c.3858G>T(p.Val1286=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0047 in 1,614,190 control chromosomes in the GnomAD database, including 22 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0031 ( 2 hom., cov: 33)
Exomes 𝑓: 0.0049 ( 20 hom. )

Consequence

LAMB2
NM_002292.4 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: -1.00
Variant links:
Genes affected
LAMB2 (HGNC:6487): (laminin subunit beta 2) Laminins, a family of extracellular matrix glycoproteins, are the major noncollagenous constituent of basement membranes. They have been implicated in a wide variety of biological processes including cell adhesion, differentiation, migration, signaling, neurite outgrowth and metastasis. Laminins, composed of 3 non identical chains: laminin alpha, beta and gamma (formerly A, B1, and B2, respectively), form a cruciform structure consisting of 3 short arms, each formed by a different chain, and a long arm composed of all 3 chains. Each laminin chain is a multidomain protein encoded by a distinct gene. Several isoforms of each chain have been described. Different alpha, beta and gamma chain isomers combine to give rise to different heterotrimeric laminin isoforms which are designated by Arabic numerals in the order of their discovery, i.e. alpha1beta1gamma1 heterotrimer is laminin 1. The biological functions of the different chains and trimer molecules are largely unknown, but some of the chains have been shown to differ with respect to their tissue distribution, presumably reflecting diverse functions in vivo. This gene encodes the beta chain isoform laminin, beta 2. The beta 2 chain contains the 7 structural domains typical of beta chains of laminin, including the short alpha region. However, unlike beta 1 chain, beta 2 has a more restricted tissue distribution. It is enriched in the basement membrane of muscles at the neuromuscular junctions, kidney glomerulus and vascular smooth muscle. Transgenic mice in which the beta 2 chain gene was inactivated by homologous recombination, showed defects in the maturation of neuromuscular junctions and impairment of glomerular filtration. Alternative splicing involving a non consensus 5' splice site (gc) in the 5' UTR of this gene has been reported. It was suggested that inefficient splicing of this first intron, which does not change the protein sequence, results in a greater abundance of the unspliced form of the transcript than the spliced form. The full-length nature of the spliced transcript is not known. [provided by RefSeq, Aug 2011]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.48).
BP6
Variant 3-49123571-C-A is Benign according to our data. Variant chr3-49123571-C-A is described in ClinVar as [Likely_benign]. Clinvar id is 472482.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-49123571-C-A is described in Lovd as [Benign]. Variant chr3-49123571-C-A is described in Lovd as [Likely_benign].
BP7
Synonymous conserved (PhyloP=-1 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.00309 (470/152338) while in subpopulation NFE AF= 0.00454 (309/68024). AF 95% confidence interval is 0.00413. There are 2 homozygotes in gnomad4. There are 211 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High Homozygotes in GnomAd at 2 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
LAMB2NM_002292.4 linkuse as main transcriptc.3858G>T p.Val1286= synonymous_variant 25/32 ENST00000305544.9
LAMB2XM_005265127.5 linkuse as main transcriptc.3858G>T p.Val1286= synonymous_variant 26/33

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
LAMB2ENST00000305544.9 linkuse as main transcriptc.3858G>T p.Val1286= synonymous_variant 25/321 NM_002292.4 P1
LAMB2ENST00000418109.5 linkuse as main transcriptc.3858G>T p.Val1286= synonymous_variant 26/331 P1
LAMB2ENST00000469665.1 linkuse as main transcriptn.88G>T non_coding_transcript_exon_variant 2/32
LAMB2ENST00000477225.1 linkuse as main transcriptn.289G>T non_coding_transcript_exon_variant 2/22

Frequencies

GnomAD3 genomes
AF:
0.00309
AC:
470
AN:
152220
Hom.:
2
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00169
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00392
Gnomad ASJ
AF:
0.00346
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.000471
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.00454
Gnomad OTH
AF:
0.00526
GnomAD3 exomes
AF:
0.00306
AC:
769
AN:
251472
Hom.:
1
AF XY:
0.00308
AC XY:
418
AN XY:
135910
show subpopulations
Gnomad AFR exome
AF:
0.00105
Gnomad AMR exome
AF:
0.00373
Gnomad ASJ exome
AF:
0.00437
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.000196
Gnomad FIN exome
AF:
0.000554
Gnomad NFE exome
AF:
0.00473
Gnomad OTH exome
AF:
0.00375
GnomAD4 exome
AF:
0.00487
AC:
7118
AN:
1461852
Hom.:
20
Cov.:
34
AF XY:
0.00473
AC XY:
3443
AN XY:
727230
show subpopulations
Gnomad4 AFR exome
AF:
0.000896
Gnomad4 AMR exome
AF:
0.00420
Gnomad4 ASJ exome
AF:
0.00402
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.000267
Gnomad4 FIN exome
AF:
0.000450
Gnomad4 NFE exome
AF:
0.00585
Gnomad4 OTH exome
AF:
0.00397
GnomAD4 genome
AF:
0.00309
AC:
470
AN:
152338
Hom.:
2
Cov.:
33
AF XY:
0.00283
AC XY:
211
AN XY:
74502
show subpopulations
Gnomad4 AFR
AF:
0.00168
Gnomad4 AMR
AF:
0.00392
Gnomad4 ASJ
AF:
0.00346
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.000207
Gnomad4 FIN
AF:
0.000471
Gnomad4 NFE
AF:
0.00454
Gnomad4 OTH
AF:
0.00520
Alfa
AF:
0.00451
Hom.:
2
Bravo
AF:
0.00353
Asia WGS
AF:
0.000289
AC:
1
AN:
3478
EpiCase
AF:
0.00513
EpiControl
AF:
0.00498

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:4
Likely benign, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenJan 01, 2024LAMB2: BP4, BP7, BS2 -
Likely benign, no assertion criteria providedclinical testingClinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center-- -
Likely benign, no assertion criteria providedclinical testingGenome Diagnostics Laboratory, University Medical Center Utrecht-- -
Benign, criteria provided, single submitterclinical testingAthena DiagnosticsJul 19, 2019- -
Pierson syndrome;C3280113:LAMB2-related infantile-onset nephrotic syndrome Benign:2
Likely benign, criteria provided, single submitterclinical testingFulgent Genetics, Fulgent GeneticsJul 19, 2021- -
Benign, criteria provided, single submitterclinical testingInvitaeJan 29, 2024- -
not specified Benign:1
Likely benign, criteria provided, single submitterclinical testingGenetic Services Laboratory, University of ChicagoNov 03, 2017- -
LAMB2-related infantile-onset nephrotic syndrome Benign:1
Likely benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaApr 27, 2017This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. -
Pierson syndrome Benign:1
Likely benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaApr 27, 2017This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.48
Cadd
Benign
1.3
Dann
Benign
0.77

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs34967349; hg19: chr3-49161004; API